Medicamen Biotech Ltd's facility at Bhiwadi receives final EU GMP approval from GREECE

Medicamen Biotech Limited's General Tablets and Liquid Orals Formulation facility located at SP 1192 A & B, Phase IV, Industrial Area, Bhiwadi - 301019 received the final approval (EU GMP Certification) today, from the Inspection Department, Division of Production & Distribution Control, National Organisation for Medicines, GREECE.

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 443.60 as compared to the previous close of Rs. 435.20. The total number of shares traded during the day was 2520 in over 316 trades.

The stock hit an intraday high of Rs. 457.00 and intraday low of 437.20. The net turnover during the day was Rs. 1131288.00.

Source : Equity Bulls

Keywords

MEDICAMENBIOTECH INE646B01010 EUGMP Approval BhiwadiFacility